Seelos Therapeutics
SEEL
#10724
Rank
A$0.3 M
Marketcap
A$0.52
Share price
-31.49%
Change (1 day)
-98.30%
Change (1 year)

Earnings for Seelos Therapeutics (SEEL)

Earnings in 2024 (TTM): A$6.97 Million

According to Seelos Therapeutics 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$53.03 Million, an increase over its 2022 earnings that were of -A$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seelos Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$6.97 M-113.15%
2023 -A$53.03 Million-48.58%
2022 -A$0.11 Billion14.07%
2021 -A$90.4 Million240.34%
2020 -A$26.57 Million-62.76%
2019 -A$71.33 Million587.73%
2018 -A$10.38 Million-36.54%
2017 -A$16.35 Million74.83%
2016 -A$9.35 Million-63.26%
2015 -A$25.45 Million-18.06%
2014 -A$31.06 Million46.19%
2013 -A$21.24 Million-31.67%
2012 -A$31.09 Million
2010 -A$29.13 Million448.63%
2009 -A$5.31 Million-25.83%
2008 -A$7.16 Million-45.65%
2007 -A$13.17 Million2.82%
2006 -A$12.81 Million-41.86%
2005 -A$22.03 Million-9.27%
2004 -A$24.28 Million114.92%
2003 -A$11.3 Million-70.78%
2002 -A$38.66 Million60.2%
2001 -A$24.13 Million70.3%
2000 -A$14.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.21 Billion-3,626.04%๐Ÿ‡บ๐Ÿ‡ธ USA